Skip to main content

Green Thumb Industries Inc (GTII-CN) Quote

Unchecking box will stop auto data updates
CSE Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 12.820
Day High 13.580
Open:12.960
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Green Thumb Industries Inc is a vertically integrated cannabis operator that focuses on limited-licensed markets in the United States.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Latest Press Releases

Green Thumb Industries (GTI) to Open Rise Hermitage, the Seventh Rise(TM) Cannabis Store in Pennsylvania, on September 19
- GlobeNewswire - Fri Sep 13, 6:55AM CDT
GlobeNewswire - CMTX
Fri Sep 13, 6:55AM CDT
Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise(TM) and Essence retail stores, today announced it will open Rise Hermitage, the seventh Rise(TM) retail location in Pennsylvania, on September 19.
Green Thumb Industries (GTI) Announces Conference Participation for September 2019
- GlobeNewswire - Thu Sep 5, 6:01AM CDT
GlobeNewswire - CMTX
Thu Sep 5, 6:01AM CDT
Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of the Rise(TM) and Essence retail stores, today announced that its executive team will participate in the following conferences in September 2019:
Demand for Craft Cannabis Swells as Medical Patients Look for Alternative Treatments
- PR Newswire - Wed Sep 4, 8:00AM CDT
PR Newswire - CMTX
Wed Sep 4, 8:00AM CDT
The burden of dealing with symptoms associated with medical conditions has financially and physically ravaged millions of people around the globe. Every day, people suffering from medical conditions are distraught by the harsh effects of the symptoms derived from their ailments. For instance, patients receiving cancer therapy can face a plethora of side effects such as nausea and severe pain. Generally, patients take a plethora of medicines in order to subdue these side effects, and in particular, cancer patients suffering from chronic pain may be prescribed dangerous opioids from their physician. As a result, more medical institutions are beginning to recommend cannabis as an alternative to treat the adverse conditions associated with cancer. The American Cancer Society has even cited studies that determined that marijuana can be helpful in treating the side effects of cancer chemotherapy. A few studies have even uncovered that inhaled (smoked or vaporized) marijuana can help with the treatment of neuropathic pain. And more recently, scientists have also reported that THC and other cannabinoids such as CBD can slow the growth of and possibly even eliminate cancer cells, ultimately reducing the spread of certain forms of cancer. Other studies have also suggested that cannabinoids can be safe for humans in treating cancer, which has led to the widespread use of medical cannabis around the world. Now, as more global government agencies collect positive data from clinical trials, additional nations will move towards legalizing medical cannabis because of its potentially valuable therapeutic effects. And as a result, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025 while registering a CAGR of 34.6%, according to data compiled by Grand View Research. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Sundial Growers Inc. (NASDAQ: SNDL), Aphria Inc. (NYSE: APHA) (TSX: APHA), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), Green Thumb Industries Inc. (OTC: GTBIF) (CSE: GTII)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 10.410 +27.95% increase
on 08/26/19
Period Open:11.500
Price movement based on the high, low and last over the given period.
13.580 -1.91% decrease
on 09/16/19
+1.820 (+15.83%) increase
since 08/16/19
3-Month 10.410 +27.95% increase
on 08/26/19
Period Open:13.150
Price movement based on the high, low and last over the given period.
15.150 -12.08% decrease
on 07/02/19
+0.170 (+1.29%) increase
since 06/14/19
52-Week 10.080 +32.14% increase
on 12/28/18
Period Open:21.660
Price movement based on the high, low and last over the given period.
32.500 -59.02% decrease
on 09/18/18
-8.340 (-38.50%) decrease
since 09/14/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).